Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2- Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 01, 2019
Efficacy and Safety Results of the Afatinib Expanded Access Program.
Journal: Oncology and therapy
Published: February 09, 2017
Showing 1-2 of 2
Last Updated: 09/26/2026